stress mood

Lactobacillus Helveticus Stress Randomized Trial Evidence Table

Structured evidence table for Lactobacillus Helveticus Stress Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Lactobacillus Helveticus Stress Randomized TrialAmong the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs.2Drzymała S (2026)The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial.
Lactobacillus Helveticus Stress Randomized TrialBackground : Recovering from COVID-19 does not always lead to complete recovery, and many patients report symptoms of anxiety and depression.2Drzymała S (2026)The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial.
Lactobacillus Helveticus Stress Randomized TrialThe aim of this study was to evaluate the impact of psychobiotic therapy on the effectiveness of treating anxiety and depressive symptoms in individuals who had previously experienced COVID-19.2Drzymała S (2026)The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial.
topicLactobacillus Helveticus Stress Randomized Trial
claimAmong the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs.
evidence level2
citationDrzymała S (2026)
sourceThe Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial.
topicLactobacillus Helveticus Stress Randomized Trial
claimBackground : Recovering from COVID-19 does not always lead to complete recovery, and many patients report symptoms of anxiety and depression.
evidence level2
citationDrzymała S (2026)
sourceThe Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial.
topicLactobacillus Helveticus Stress Randomized Trial
claimThe aim of this study was to evaluate the impact of psychobiotic therapy on the effectiveness of treating anxiety and depressive symptoms in individuals who had previously experienced COVID-19.
evidence level2
citationDrzymała S (2026)
sourceThe Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial.

Learn next

Related evidence and supplement guides

GuideRhodiola Rosea: Adaptogen Evidence Review for Fatigue and StressLegacy library material — check the original sources.GuideAshwagandha: What the Evidence Actually Says About Stress and CortisolLegacy library material — check the original sources.AnswerDoes Glutathione Oxidative Stress Randomized Trial work?Legacy library material — check the original sources.AnswerIs Glutathione Oxidative Stress Randomized Trial safe?Legacy library material — check the original sources.AnswerWhat does the evidence say about Glutathione Oxidative Stress Randomized Trial?Legacy library material — check the original sources.AnswerDoes Saffron Mood Stress Randomized Trial work?Legacy library material — check the original sources.

Source documents

  1. The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome-A Randomized, Double-Blind, Placebo-Controlled Trial.